Valproic acid Completed Phase 4 Trials for Oppositional Defiant Disorder / Attention Deficit Disorder With Hyperactivity Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00228046Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder